Company / Total Assets
Xeris Biopharma Holdings, Inc. Total Assets History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$383.5M
FY2025
5-year range
$304.4M / $383.5M
FY2021-FY2025
Trend
+18.7%
vs FY2024
Sector context
#163 of 214
Health Care
What the data says
Xeris Biopharma Holdings, Inc.'s total assets of $384M is lower than 76% of companies in the Health Care sector (FY2025). Improved from $323M to $384M over the past 2 years.
Based on SEC 10-K filings.
$384M in FY2025 with a 5-year CAGR of +19.2%.
Improved from $323M to $384M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +3.6%
- 5-Year CAGR
- +19.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 24% in Health CareTop 76% of 214This company $383.5M Sector average $7.5B
▼
-94.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +19.2%, indicating consistent growth.
- In FY2025, total assets increased 18.7% year-over-year.
- Ranks #163 out of 214 companies in the Health Care sector.
- Lowest total assets in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -0.26 (distress zone, below 1.8 threshold)
- Negative profit margin: -27.0%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $383.5M | +18.7% |
| FY2024 | $323.1M | +0.1% |
| FY2023 | $322.6M | -6.4% |
| FY2022 | $344.5M | +13.2% |
| FY2021 | $304.4M | +91.2% |
| FY2020 | $159.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026